Robert Sanford
Urology · Los Angeles, CANPI 1578522785
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $503 and has fallen 81.3% since, to $94 in 2025. That places this record below the midpoint for urology clinicians in CA, where the typical reported total is $2,485.
Across 78 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rochester Medical Corporation$180
- BD$161
- C. R. Bard, Inc. & Subsidiaries$153
- Johnson & Johnson$130
- Antares Pharma, Inc.$115
- AbbVie$115
- plus $546 from 14 others
What the payments were for
- Food & beverage$1,31994%
- Education$806%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rochester Medical Corporation | 15 | $180 |
| BD | 11 | $161 |
| C. R. Bard, Inc. & Subsidiaries | 9 | $153 |
| Johnson & Johnson | 10 | $130 |
| Antares Pharma, Inc. | 7 | $115 |
| AbbVie | 5 | $115 |
| Astellas Pharma US Inc | 2 | $100 |
| Coloplast | 3 | $85 |
| Procept Biorobotics Corporation | 2 | $60 |
| Blue Earth Diagnostics | 2 | $50 |
| Boston Scientific | 2 | $41 |
| Laborie Medical Technologies Corp. | 1 | $41 |
| Neotract Inc. | 1 | $31 |
| Pfizer | 2 | $31 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Profound Medical Corp. | 1 | $18 |
| Angiodynamics, Inc. | 1 | $18 |
| Metuchen Pharmaceuticals | 1 | $16 |
| Dendreon Pharmaceuticals LLC | 1 | $14 |
How this compares
$1,399 in reported general payments places this provider in the 35th percentile of 1,324 urology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 14 | $291 |
Paid to pharmacies, not to this prescriber.
Other urology in Los Angeles
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.5M
- Stuart HoldenLos Angeles$1.1M
- William AronsonLos Angeles$540K
- Amir LebastchiLos Angeles$478K
- Nazy ZomorodianLos Angeles$309K
- Jeffrey Loh-DoyleLos Angeles$308K
- Siamak DaneshmandLos Angeles$306K
- Karim ChamieLos Angeles$291K
- Brian ShuchLos Angeles$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.